Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis

Fox, Caroline S, Matsushita, Kunihiro, Woodward, Mark, Bilo, Henk JG, Chalmers, John, Heerspink, Hiddo J Lambers, Lee, Brian J, Perkins, Robert M +9 more·2012·The Lancet

DOI 10.1016/s0140-6736(12)61350-6

Cited by (1,001)

Items 301–400 of 1,001

Albuminuria, Lung Function Decline, and Risk of Incident Chronic Obstructive Pulmonary Disease. The NHLBI Pooled Cohorts Study
Elizabeth C. Oelsner, Pallavi Balte, Morgan Erika Grams, Patricia A. Cassano, David R. Jacobs, R. Graham Barr, Kristin M. Burkart, Ravi Kalhan, Richard A. Kronmal, Laura R. Loehr et al. · 2018 · American Journal of Respiratory and Critical Care Medicine
Measuring and Assessing Kidney Function
Priya Vart, Morgan Erika Grams · 2016 · Seminars in Nephrology
Albuminuria: Prevalence, associated risk factors and relationship with cardiovascular disease
Chen Fang, Wenying Yang, Jianping Weng, Weiping Jia, Linong Ji, Jianzhong Xiao, Zhongyan Shan, Jie Liu, Haoming Tian, Qiuhe Ji et al. · 2013 · Journal of Diabetes Investigation
Trends in Statin Use Among US Adults With Chronic Kidney Disease, 1999–2014
Matthew T. Mefford, Robert S. Rosenson, Luqin Deng, Rikki M. Tanner, Vera Bittner, Monika M. Safford, Blai Coll, Katherine E. Mues, Keri L. Monda, Paul Muntner · 2019 · Journal of the American Heart Association
Cumulative Risk of End-Stage Renal Disease Among Patients With Type 2 Diabetes: A Nationwide Inception Cohort Study
Patrik Finne, Per‐Henrik Groop, Martti Arffman, Marjo Kervinen, Jaakko Helve, Carola Grönhagen‐Riska, Reijo Sund · 2019 · Diabetes Care
Plasma Metabolomics Identifies Markers of Impaired Renal Function: A Meta-analysis of 3089 Persons with Type 2 Diabetes
Nete Tofte, Nicole Vogelzangs, Dennis Owen Mook-Kanamori, Adela Brahimaj, Jana Nano, Fariba Ahmadizar, Ko Willems van Dijk, Marie Frimodt‐Møller, Ilja C.W. Arts, Joline W. J. Beulens et al. · 2020 · The Journal of Clinical Endocrinology & Metabolism
Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly
B. Sjöberg, Abdul Rashid Qureshi, Olof Heimbürger, Peter Stenvinkel, Lars Lind, Anders Olof Larsson, Peter F. Barany, Johan Ärnlöv · 2015 · Journal of Internal Medicine
Combination of Changes in Estimated GFR and Albuminuria and the Risk of Major Clinical Outcomes
Toshiaki Ohkuma, Min Jun, John Philip Chalmers, Mark Emmanuel Cooper, Pavel Hamet, Stephen B. Harrap, Sophia Zoungas, Vlado Perkovic, Mark Woodward, on behalf of the ADVANCE Collaborative Group · 2019 · Clinical Journal of the American Society of Nephrology
Metformin: time to review its role and safety in chronic kidney disease
Cara Tanner, Gayathiri Wang, Nancy Liu, Sofianos Andrikopoulos, Jeffrey D. Zajac, Elif Ilhan Ekinci · 2019 · The Medical Journal of Australia
Cost-Effectiveness of Dapagliflozin for Non-diabetic Chronic Kidney Disease
Rebecca Lauren Tisdale, Marika Mae Cusick, Kelly Zhang Aluri, Thomas J. Handley, Alice Kate Cummings Joyner, Joshua A. Salomon, Glenn Matthew Chertow, Jeremy D. Goldhaber‐Fiebert, Douglas K Owens · 2022 · Journal of General Internal Medicine
High normal albuminuria is independently associated with aortic stiffness in patients with Type 2 diabetes
Jianjun Liu, S. Tavintharan, Lee Ying Yeoh, Chee Fang Sum, Xiao Wei Ng, Sharon Li Ting Pek, S. B. M. Lee, Wern Ee Tang, Su Chi Lim, the SMART2D study · 2014 · Diabetic Medicine
Five-Year Incidence of Chronic Kidney Disease (Stage 3-5) and Associated Risk Factors in a Spanish Cohort: The MADIABETES Study
Miguel Ángel Salinero-Fort, F. Javier San Andrés-Rebollo, Carmen de Burgos‐Lunar, Paloma Gómez‐Campelo, Rosa M. Chico-Moraleja, Ana López‐de‐Andrés, Rodrigo Jiménez‐García, MADIABETES Group · 2015 · PLoS ONE
Determinants of mortality in patients with type 2 diabetes: a review
Jana Engelmann, Ulf Manuwald, Constanze Rubach, Joachim Kügler, Andreas L. Birkenfeld, M Hanefeld, Ulrike Rothe · 2016 · Reviews in Endocrine and Metabolic Disorders
Effectiveness of dapagliflozin versus comparators on renal endpoints in the real world: A multicentre retrospective study
Gian Paolo Fadini, Anna Solini, Maria Laura Manca, Giuseppe Penno, Adriano Gatti, Roberto Anichini, Stefano Del Prato, Angelo Avogaro, For The DARWIN‐T2D Network · 2018 · Diabetes Obesity and Metabolism
Energy restriction in renal protection
Siyang Wang, Guangyan Cai, Xiangmei Chen · 2018 · British Journal Of Nutrition
Renal hyperfiltration is independently associated with increased all-cause mortality in individuals with type 2 diabetes: a prospective cohort study
Giuseppe Penno, Emanuela Orsi, Anna Solini, Enzo Bonora, Cecilia Fondelli, Roberto Trevisan, Monica Vedovato, Franco Luigi Cavalot, Gabriella Gruden, Luigi Laviola et al. · 2020 · BMJ Open Diabetes Research & Care
Genetics of Diabetic Nephropathy: a Long Road of Discovery
Amy Jayne McKnight, Seamus Duffy, Alexander Peter Maxwell · 2015 · Current Diabetes Reports
The residual cardiorenal risk in type 2 diabetes
Dario Giugliano, Maria Ida Maiorino, Giuseppe Bellastella, Katherine Esposito · 2021 · Cardiovascular Diabetology
Diagnostic Accuracy of Point-of-Care Tests for Detecting Albuminuria: A Systematic Review and Meta-analysis
McTaggart, Malcolm P., Newall, Ronald G., Hirst, Jennifer A., Bankhead, Clare R., Lamb, Edmund J., Roberts, Nia W., Price, Christopher P. · 2014 · Annals of Internal Medicine
Body Mass Index and Risk of Diabetic Nephropathy: A Mendelian Randomization Study
Jingru Lu, Xiaoshuang Liu, Song Jiang, Shuyan Kan, Yu An, Chun-Xia Zheng, Xiang Li, Zhihong Liu, Guotong Xie · 2022 · The Journal of Clinical Endocrinology & Metabolism
SGLT2 inhibitors for patients with type 2 diabetes and CKD: a narrative review
Merlin C. Thomas, Brendon Lange Neuen, Stephen Morris Twigg, Mark Emmanuel Cooper, Sunil V. Badve · 2023 · Endocrine Connections
The role of innate immunity in diabetic nephropathy and their therapeutic consequences
Min Yang, Chun Zhang · 2023 · Journal of Pharmaceutical Analysis
Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines
Oksana M. Drapkina, Концевая Анна Васильевна, А. М. Калинина, Sergey Nikolaevich Avdeev, Агальцов Михаил Викторович, Л. И. Алексеева, I. I. Almazova, Е. Yu. Andreenko, D. N. Antipushina, Yu. А. Balanova et al. · 2024 · CARDIOVASCULAR THERAPY AND PREVENTION
Developments in albuminuria testing: A key biomarker for detection, prognosis and surveillance of kidney and cardiovascular disease—A practical update for clinicians
Jelle M. Beernink, Dominique van Mil, Gozewijn Dirk Laverman, Hiddo J.L. Heerspink, Ron T. Gansevoort · 2025 · Diabetes Obesity and Metabolism
Drinking Pattern and Risk of Chronic Kidney Disease: The Kansai Healthcare Study
Kyoko Satō, Tomoshige Hayashi, Shinichiro Uehara, Shigeki Kinuhata, Keiko Oue, Ginji Endo, Hiroshi Kambe, Kanji Fukuda · 2014 · American Journal of Nephrology
Chronic kidney disease and risk factors responsible for sudden cardiac death: a whiff of hope?
Márcio Galindo Kiuchi, Décio Mion · 2015 · Kidney Research and Clinical Practice
Risk-Factor Profile of Living Kidney Donors
Philip A. Clayton, John R. Saunders, Stephen Peter McDonald, Richard D. M. Allen, Helen Pilmore, Alan C. Saunder, Neil C Boudville, Steven James Chadban · 2016 · Transplantation
Prevention of renal failure in Chinese patients with newly diagnosed type 2 diabetes: A cost‐effectiveness analysis
Bin Wu, Suhua Zhang, Hou‐Wen Lin, Shan Mou · 2017 · Journal of Diabetes Investigation
Intersection Between Chronic Kidney Disease and Cardiovascular Disease
Luke Joseph Laffin, George L. Bakris · 2021 · Current Cardiology Reports
Prognostic clinical and molecular biomarkers of renal disease in type 2 diabetes
Michelle J. Pena, Dick de Zeeuw, Harald Mischak, Joachim Jankowski, Rainer W. Oberbauer, Wolfgang Woloszczuk, Jacqueline Benner, Guido Dallmann, Bernd Mayer, Gert J. Mayer et al. · 2015 · Nephrology Dialysis Transplantation
Effects of Low Muscle Mass on Albuminuria and Chronic Kidney Disease in Patients With Type 2 Diabetes: The Korean Sarcopenic Obesity Study (KSOS)
Hye Soo Chung, Soon Young Hwang, Ju Hee Choi, Hyun Jung Lee, Hye Jin Yoo, Ji A Seo, Sin Gon Kim, Nan Hee Kim, Dong Seop Choi, Sei Hyun Baik et al. · 2017 · The Journals of Gerontology Series A
Albuminuria, the High-Density Lipoprotein Proteome, and Coronary Artery Calcification in Type 1 Diabetes Mellitus
Baohai Shao, Leila R. Zelnick, Jake Wimberger, Jonathan Himmelfarb, John D. Brunzell, William Sean Davidson, Janet K. Snell‐Bergeon, Karin Bornfeldt, Ian H. de Boer, Jay W. Heinecke · 2019 · Arteriosclerosis Thrombosis and Vascular Biology
Renal function and lipid metabolism are major predictors of circumpapillary retinal nerve fiber layer thickness—the LIFE-Adult Study
Franziska Georgia Rauscher, Mengyu Wang, Mike Francke, Kerstin Wirkner, Anke Tönjes, Christoph Engel, Joachim Thiery, Peter Stenvinkel, Michael Stümvoll, Markus Loeffler et al. · 2021 · BMC Medicine
Therapeutic Potential of Resveratrol in Diabetic Nephropathy According to Molecular Signaling
Marziyeh Salami, Raziyeh Salami, Alireza Mafi, Mohammad Hossein Aarabi, Omid Vakili, Zatollah Asemi · 2021 · Current Molecular Pharmacology
New Targets for Extracorporeal Blood Purification Therapies in Sepsis
Céline Monard, Paul Samuel Abraham, Antoine Guillaume Schneider, Thomas Rimmelé · 2022 · Blood Purification
Sympathetic Activation in Hypertensive Chronic Kidney Disease – A Stimulus for Cardiac Arrhythmias and Sudden Cardiac Death?
Kiuchi, Márcio Galindo, Ho, Jan K., Nolde, Janis Marc, Gavidia, Leslie Marisol Lugo, Carnagarin, Revathy, Matthews, Vance B., Schlaich, Markus P. · 2020 · Frontiers in Physiology
Mortality and mode of dialysis: meta-analysis and systematic review
Subhash Chander, Sindhu Luhana, FNU Sadarat, Om Parkash, Zubair Rahaman, Hong Yu Wang, FNU Kiran, Abhi Chand Lohana, Fnu Sapna, Roopa Kumari · 2024 · BMC Nephrology
Effect of Processing Delay and Storage Conditions on Urine Albumin-to-Creatinine Ratio
William Guy Herrington, Nicola Illingworth, Natalie Staplin, Aishwarya P R Kumar, Ben Storey, Renata Hrusecka, Parminder K. Judge, Maria Mahmood, Sarah Parish, Martin Landray et al. · 2016 · Clinical Journal of the American Society of Nephrology
Association of estimated glomerular filtration rate and proteinuria with all-cause mortality in community-based population in China: A Result from Kailuan Study
Jianwei Wu, Jiaokun Jia, Zhaoxia Li, Hua Pan, Anxin Wang, Xiuhua Guo, Shouling Wu, Xingquan Zhao · 2018 · Scientific Reports
General practitioners’ perspectives on management of early-stage chronic kidney disease: a focus group study
Carola van Dipten, Saskia van Berkel, Wim J. C. de Grauw, Nynke Scherpbier‐de Haan, Bouke Brongers, Karel van Spaendonck, Jack F.M. Wetzels, Willem JJ Assendelft, Marianne Dees · 2018 · BMC Family Practice
Compensatory Hippocampal Connectivity in Young Adults With Early-Stage Type 2 Diabetes
Fang Fang, Mengyu Lai, Jingjing Huang, Mei Kang, Mingming Ma, Kangan Li, Jingge Lian, Zheng Wang, Dazhi Yin, Yufan Wang · 2019 · The Journal of Clinical Endocrinology & Metabolism
Treatment and impact of dyslipidemia in diabetic nephropathy
Tadashi Toyama, Miho Shimizu, Kengo Furuichi, Shuichi Kaneko, Takashi Wada · 2013 · Clinical and Experimental Nephrology
Fasting Urinary Osmolality, CKD Progression, and Mortality: A Prospective Observational Study
Nahid Tabibzadeh, Sandra Wagner, Marie Metzger, Martin Flamant, Pascal Houillier, Jean‐Jacques Boffa, François Vrtovsnik, Éric Thervet, Bénédicte Stengel, Jean‐Philippe Haymann et al. · 2019 · American Journal of Kidney Diseases
Cardiovascular and all-cause mortality in patients with type 2 diabetes mellitus in the MADIABETES Cohort Study: Association with chronic kidney disease
Salinero-Fort, Miguel Ángel, San Andrés-Rebollo, Francisco Javier, de Burgos-Lunar, Carmen, Abánades-Herranz, Juan Carlos, Carrillo-de-Santa-Pau, Enrique, Chico-Moraleja, Rosa María, Jiménez-García, Rodrigo, López-de-Andrés, Ana, Gómez-Campelo, Paloma · 2016 · Journal of Diabetes and its Complications
Preventing major adverse cardiovascular events by SGLT-2 inhibition in patients with type 2 diabetes: the role of kidney
Dario Giugliano, Luca De Nicola, Maria Ida Maiorino, Giuseppe Bellastella, Carlo Garofalo, Paolo Chiodini, Antonio Ceriello, Katherine Esposito · 2020 · Cardiovascular Diabetology
Prospective bidirectional associations between depression and chronic kidney diseases
Xiaowei Zheng, Wenyan Wu, Suwen Shen · 2022 · Scientific Reports
Diabetic kidney disease in A ustralia: Current burden and future projections
Sarah White, Steven James Chadban · 2014 · Nephrology
Cardiac troponin and C-reactive protein for predicting all-cause and cardiovascular mortality in patients with chronic kidney disease: A meta-analysis
Wei-Jie Li, Xumiao Chen, Xiao‐Ying Nie, Jing Zhang, Yun‐Jiu Cheng, Xiao‐Xiong Lin, Su‐Hua Wu · 2015 · Clinics
Kaiser Permanente Creatinine Safety Program: A Mechanism to Ensure Widespread Detection and Care for Chronic Kidney Disease
John J. Sim, Mark Rutkowski, David C. Selevan, Michael Batech, Royann Timmins, Jeff M. Slezak, Steven J. Jacobsen, Michael H. Kanter · 2015 · The American Journal of Medicine
EMPA-REG and Other Cardiovascular Outcome Trials of Glucose-lowering Agents: Implications for Future Treatment Strategies in Type 2 Diabetes Mellitus
Guntram Schernthaner, Marie Helene Schernthaner-Reiter, Gerit-Holger Schernthaner · 2016 · Clinical Therapeutics
Lorcaserin and Renal Outcomes in Obese and Overweight Patients in the CAMELLIA-TIMI 61 Trial
B. Scirica, E. Bohula, J. Dwyer, Arman Qamar, S. Inzucchi, Darren K Mcguire, A. Keech, Steven R. Smith, S. Murphy, K. Im et al. · 2019 · Circulation
Creatinine versus cystatin C for renal function-based mortality prediction in an elderly cohort: The Northern Manhattan Study
Joshua Zebadiah Willey, Yeseon Park Moon, Syed Ali Husain, Mitchell S.V. Elkind, Ralph L. Sacco, Myles Selig Wolf, Ken Cheung, Clinton B. Wright, Sumit Mohan · 2020 · PLoS ONE
Chronic kidney disease measures for cardiovascular risk prediction
Yejin Mok, Shoshana H. Ballew, Kunihiro Matsushita · 2021 · Atherosclerosis
Serum uric acid levels and diabetic kidney disease in patients with type 2 diabetes mellitus: A dose-response meta-analysis
Pan Ji, Jieyun Zhu, Jihua Feng, Hongyuan Li, Yu Qiao, Han Qin, Lile Wei, Jianfeng Zhang · 2022 · Primary care diabetes
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
2020 · Revista Española de Cardiología (English Edition)
Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)
David M. Charytan, Eldrin Foster Lewis, Akshay Suvas Desai, Larry A. Weinrauch, Peter T. Ivanovich, Robert D. Toto, Brian Lee Claggett, Jiankang Liu, L. Howard Hartley, Peter V. Finn et al. · 2015 · American Journal of Kidney Diseases
Chronic Renal Disease and Risk of Cardiovascular Morbidity-Mortality
Antonio Santoro, Marcora Mandreoli · 2014 · Kidney & Blood Pressure Research
Changes in serum metabolites with the stage of chronic kidney disease: Comparison of diabetes and non-diabetes
Jueun Lee, Ji‐Young Choi, Yong‐Kook Kwon, Doohae Lee, Hee‐Yeon Jung, Hye‐Myung Ryu, Jang‐Hee Cho, Do Hyun Ryu, Yong-Lim Kim, Geum‐Sook Hwang · 2016 · Clinica Chimica Acta
Lipids, Blood Pressure, Kidney-what was New in 2012?
Maciej Banach, Dagmara Hering, Krzysztof Narkiewicz, Michał Myśliwiec, Jacek Rysz, Jolanta Małyszko · 2012 · International Journal of Pharmacology
Real-world effectiveness of adding newer generation GLP-1RA to SGLT2i in type 2 diabetes
Nathorn Chaiyakunapruk, Xi Tan, Yuanjie Michael Liang, Mico Guevarra, Lin Xie, ALICE Y.Y. CHENG · 2025 · Cardiovascular Diabetology
Comparison of the heart failure risk stratification performance of the CKD – EPI equation and the MDRD equation for estimated glomerular filtration rate in patients with Type 2 diabetes
Yangchun Wang, Peter Todd Katzmarzyk, Ron Horswell, Weigang Zhao, John Johnson, Gang Hu · 2015 · Diabetic Medicine
Combined Effects of Smoking and Bilirubin Levels on the Risk of Lung Cancer in Korea: The Severance Cohort Study
Jung‐Eun Lim, Heejin Kimm, Sun Ha Jee · 2014 · PLoS ONE
Uraemia: an unrecognized driver of central neurohumoral dysfunction in chronic kidney disease?
Conor F. Underwood, Cara M. Hildreth, Benjamin F. Wyse, Rochelle A. Boyd, Ann K. Goodchild, Jacqueline Kathleen Phillips · 2016 · Acta Physiologica
Disease Trajectories Before ESRD: Implications for Clinical Management
Keiichi Sumida, Csaba Pal Kovesdy · 2017 · Seminars in Nephrology
The Primary-Secondary Care Partnership to Improve Outcomes in Chronic Kidney Disease (PSP-CKD) Study: A Cluster Randomized Trial in Primary Care
Rupert Major, Celia Brown, David J. Shepherd, Stephen Rogers, Warren P. Pickering, Graham L. Warwick, Shaun R. Barber, Nuzhat Ashra, Tom Morris, Nigel John Brunskill · 2019 · Journal of the American Society of Nephrology
Association of Arterial Stiffness With Chronic Kidney Disease Progression and Mortality
Jūlija Voicehovska, Eva Bormane, Anda Grigane, Georgijs Moisejevs, Eva Moreino, Dace Trumpika, Vladimirs Voicehovskis · 2021 · Heart Lung and Circulation
CKD Prevalence Among Patients With and Without Type 2 Diabetes: Regional Differences in the United States
Xue Feng, Ryan Farej, Bonnie B. Dean, Fang Xia, Andrew Gaiser, Sheldon Xiaodong Kong, Jay Elliott, Stefanie Lindemann, Rakesh Singh · 2021 · Kidney Medicine
On the non-linear association between serum uric acid levels and all-cause mortality rate in patients with type 2 diabetes mellitus
Olga Lamacchia, Andrea Fontana, Antonio Pacilli, Massimiliano Copetti, Stefania Fariello, Monia Garofolo, Giuseppe Penno, Vincenzo Trischitta, Salvatore De Cosmo, Mauro Cignarelli · 2017 · Atherosclerosis
Continuous Glucose Monitoring to Optimize Management of Diabetes in Patients with Advanced CKD
Rodolfo Javier Galindo, Ian H. de Boer, Joshua J. Neumiller, Katherine R. Tuttle · 2022 · Clinical Journal of the American Society of Nephrology
Combining robust urine biomarkers to assess chronic kidney disease progression
Frank Bienaimé, Mordi Muorah, Marie Metzger, Mélanie Broueilh, Pascal Houiller, Martin Flamant, Jean‐Philippe Haymann, Jacky Vonderscher, Jacques L. Mizrahi, Gérard Friedlander et al. · 2023 · EBioMedicine
Creatinine-or cystatin C-based equations to estimate glomerular filtration in the general population: impact on the epidemiology of chronic kidney disease
Pierre Delanaye, Etienne Cavalier, Olivier P. Moranne, Laurence Lutteri, Jean-Marie Krzesinski, Olivier Bruyère · 2013 · BMC Nephrology
Sodium glucose cotransporter (SGLT)‐2 inhibitors: Do we need them for glucose‐lowering, for cardiorenal protection or both?
Rosalie Annemien Scholtes, Michaël J.B. van Baar, Yuliya Lytvyn, Petter Bjornstad, Max Nieuwdorp, David Z.I. Cherney, Daniël H. van Raalte · 2019 · Diabetes Obesity and Metabolism
The Argument for Abolishing Cardiac Screening of Asymptomatic Kidney Transplant Candidates
Adnan Sharif · 2019 · American Journal of Kidney Diseases
The role of direct renin inhibitors in the treatment of the hypertensive diabetic patient
Graziano Riccioni · 2013 · Therapeutic Advances in Endocrinology and Metabolism
Assessing risk in chronic kidney disease: a methodological review
Morgan Erika Grams, Josef Coresh · 2012 · Nature Reviews Nephrology
The association between fine particulate matter (PM2.5) and chronic kidney disease using electronic health record data in urban Minnesota
Lama Ghazi, Paul E. Drawz, Jesse David Berman · 2021 · Journal of Exposure Science & Environmental Epidemiology
Vaccination Against Receptor for Advanced Glycation End Products Attenuates the Progression of Diabetic Kidney Disease
Tatsuhiko Azegami, Takashin Nakayama, Kaori Hayashi, Akihito Hishikawa, Norifumi Yoshimoto, Ran Nakamichi, Hiroshi Itoh · 2021 · Diabetes
Lipidomics Reveals Serum Specific Lipid Alterations in Diabetic Nephropathy
Tingting Xu, Xiaoyan Xu, Lu Zhang, Ke Zhang, Qiong Wei, Lin Zhu, Ying Yu, Liangxiang Xiao, Lili Lin, Wenjuan Qian et al. · 2021 · Frontiers in Endocrinology
Association between estimated glomerular filtration rate and clinical outcomes in patients with acute ischaemic stroke: results from China National Stroke Registry
Xianwei Wang, Y. Wang, Cheng Wang, X. Zhao, Ying Xian, Deren Wang, Li Liu, Yanxia Luo, Guiyou Liu, Y. Wang · 2014 · Age and Ageing
Association between periodontal disease and mortality in people with CKD: a meta-analysis of cohort studies
Jian Zhang, Hong Jiang, Min Sun, Jianghua Chen · 2017 · BMC Nephrology
Predictors of all-cause and cardiovascular disease mortality in type 2 diabetes: Diabetes Heart Study
Laura M. Raffield, Fang‐Chi Hsu, Amanda J. Cox, J. Jeffrey Carr, Barry I. Freedman, Donald W. Bowden · 2015 · Diabetology & Metabolic Syndrome
Lifetime Risk of Stage 3–5 CKD in a Community-Based Sample in Iceland
Lesley A. Inker, Hocine Tighiouart, Thor Aspelund, Vilmundur G. Gudnason, Tamara B. Harris, Ólafur S. Indridason, Runólfur Pálsson, Shani Shastri, Andrew S. Levey, Mark J. Sarnak · 2015 · Clinical Journal of the American Society of Nephrology
The impact of chronic kidney disease and cardiovascular comorbidity on mortality in a multiethnic population: a retrospective cohort study
Mark Jesky, Amanda Lambert, Andrew C Burden, Paul Cockwell · 2013 · BMJ Open
Are All Patients With Type 1 Diabetes Destined for Dialysis if They Live Long Enough? Probably Not
George L. Bakris, Mark E. Molitch · 2018 · Diabetes Care
A mitochondrial-targeted peptide ameliorated podocyte apoptosis through a HOCl-alb-enhanced and mitochondria-dependent signalling pathway in diabetic rats and in vitro
Xiaoqiao Wang, Dongdong Tang, Yao-Wei Zou, Xiaoyu Wu, Yihua Chen, Hongying Li, Siqi Chen, Yue Shi, Hongxin Niu · 2019 · Journal of Enzyme Inhibition and Medicinal Chemistry
A new strategy for vascular complications in young people with type 1 diabetes mellitus
on behalf of the Adolescent type 1 Diabetes cardio-renal Intervention Trial (AdDIT) study group, Maria Loredana Marcovecchio, R. Neil Dalton, Denis Daneman, John Eric Deanfield, Timothy William Jones, H. A. W. Neil, David B. Dunger · 2019 · Nature Reviews Endocrinology
Glomerular Filtration Rate and Associated Risks of Cardiovascular Events, Mortality, and Severe Hypoglycemia in Patients with Type 2 Diabetes: Secondary Analysis (DEVOTE 11)
Aslam Amod, John B. Buse, Darren K. McGuire, Thomas Rudolf Pieber, Rodica Pop‐Busui, Richard E. Pratley, Bernard Zinman, Marco Bo Hansen, Ting Jia, Thomas Mark et al. · 2019 · Diabetes Therapy
Effects of dapagliflozin and gliclazide on the cardiorenal axis in people with type 2 diabetes
Erik J.M. van Bommel, Mark M. Smits, Danique Ruiter, Marcel H.A. Muskiet, Mark H.H. Kramer, Max Nieuwdorp, Daan Johannes Touw, Hiddo J.L. Heerspink, Jaap A. Joles, Daniël H. van Raalte · 2020 · Journal of Hypertension
Chronic kidney disease as a cardiovascular risk factor
Rafael Carmena, Juan Francisco Ascaso, Josep Redón · 2020 · Journal of Hypertension
Neutrophil Activation and Neutrophil Extracellular Trap Formation in Dialysis Patients
Scott D. Bieber, Kimberly A. Muczynski, Christian Lood · 2020 · Kidney Medicine
Burden of chronic kidney disease and rapid decline in renal function among adults attending a hospital-based diabetes center in Northern Europe
Tomás Patrick Griffin, Paula Mary O’Shea, Andrew Smyth, Md Nahidul Islam, Deirdre Wall, John P. Ferguson, Esther O'Sullivan, Francis Martin Finucane, Seán F. Dinneen, Fidelma Dunne et al. · 2021 · BMJ Open Diabetes Research & Care
Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk
Michael Böhm, Helmut Schumacher, Christian M. Werner, Koon Kang Teo, Eva Lonn, Felix Mahfoud, Thimoteus Speer, Giuseppe Mancia, Josep Redón, Roland Erich Schmieder et al. · 2022 · Cardiovascular Diabetology
Creatinine Rise During Blood Pressure Therapy and the Risk of Adverse Clinical Outcomes in Patients With Type 2 Diabetes Mellitus: A Post Hoc Analysis of the ACCORD-BP Randomized Controlled Trial
Collard, Didier, Brouwer, Tom F., Peters, Ron J.G., Vogt, Liffert, van den Born, Bert-Jan H. · 2018 · Hypertension
Genetic and Epigenetic Risk Factors for Diabetic Kidney Disease
Amy Jayne McKnight, Gareth J. McKay, Alexander Peter Maxwell · 2014 · Advances in Chronic Kidney Disease
Inflammation biomarkers and mortality prediction in patients with type 2 diabetes (ZODIAC-27)
Gijs W.D. Landman, Nanne Kleefstra, Klaas H. Groenier, Stephan J. L. Bakker, Geert H. Groeneveld, Henk J. G. Bilo, Kornelis J. J. van Hateren · 2016 · Atherosclerosis
In Vitro Selection of Cell-Internalizing DNA Aptamers in a Model System of Inflammatory Kidney Disease
Glory Ranches, Melanie Lukasser, Herbert Schramek, Andreas Ploner, Taras Stasyk, Gert J. Mayer, Günter Mayer, Alexander Hüttenhofer · 2017 · Molecular Therapy — Nucleic Acids
Effects of renal denervation on blood pressure in hypertensive patients with end-stage renal disease: a single centre experience
C. Ott, A. Schmid, T. Ditting, R. Veelken, M. Uder, R. Schmieder · 2019 · Clinical and Experimental Nephrology
microRNA-200c regulates KLOTHO expression in human kidney cells under oxidative stress
Kenichi Morii, Satoshi Yamasaki, Shigehiro Doi, Taisuke Irifuku, Kensuke Sasaki, Toshiki Doi, Ayumu Nakashima, Koji Arihiro, Takao Masaki · 2019 · PLoS ONE
Capability of intravoxel incoherent motion and diffusion tensor imaging to detect early kidney injury in type 2 diabetes
Haoran Zhang, Peng Wang, Dafa Shi, Xiang Yao, Yanfei Li, Xuedan Liu, Yang Sun, Jie Ding, Siyuan Wang, Guangsong Wang et al. · 2022 · European Radiology
Revascularization in stable coronary artery disease
Rasha Kadem Al-Lamee, Michael J. Foley, Christopher Rajkumar, Dárrel P. Francis · 2022 · BMJ